Skip to main content
Lifecare ASA logo

Lifecare ASA — Investor Relations & Filings

Ticker · LIFE ISIN · NO0013355859 LEI · 254900D88MYGZ7JD5P39 OL Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2024-02-01 Board/Management Inform…
Country NO Norway
Listing OL LIFE

About Lifecare ASA

https://lifecare.no/

Lifecare ASA is a clinical-stage medical sensor company specializing in the development of nanotechnology for medical applications. Its core activity involves creating miniaturized, implantable, and long-term nanobiosensors for the continuous monitoring of various body analytes. The company's primary focus is on developing a sensor for correct and continuous glucose monitoring to improve diabetes management. The business model is based on developing and licensing its proprietary sensor technology to facilitate the production and sale of advanced medical devices.

Recent filings

Filing Released Lang Actions
LIFE Appointment of Production Manager
Board/Management Information Classification · 1% confidence The document announces the appointment of a new Production Manager, Torsten Ernst, effective March 1, 2024. This type of announcement, detailing changes in senior management or key personnel, directly corresponds to the definition of 'Board/Management Information'. The document is a press release format, not a comprehensive financial report (like 10-K or IR) or a regulatory filing summary (like RPA or RNS). Therefore, the appropriate code is MANG.
2024-02-01 English
Finansiell kalender
Report Publication Announcement Classification · 1% confidence The document is titled "Finansiell kalender" (Financial Calendar) and lists scheduled dates for various corporate events, specifically mentioning 'Årsrapport' (Annual Report), 'Kvartalsrapport' (Quarterly Report), and 'Ordinær generalforsamling' (Annual General Meeting). This type of document provides a schedule of future corporate disclosures and events, rather than being one of the reports itself. Since there is no specific category for a 'Financial Calendar', and it is a general announcement regarding future corporate activities and reporting dates, it best fits the general regulatory announcement category, 'Regulatory Filings' (RNS), as it is a required disclosure about the company's schedule.
2024-01-24 Norwegian
Financial calendar
Report Publication Announcement Classification · 1% confidence The document text is titled 'Financial calendar' and lists future dates for key corporate events such as the 'Annual Report', 'Quarterly Report - Q4', 'Half-yearly Report', and 'Annual General Meeting'. It is not the report itself, but rather an announcement detailing the schedule for future report publications. Given the options, this type of scheduling announcement, which informs investors about when reports will be released, best fits the 'Report Publication Announcement' (RPA) category, as it announces the publication schedule for various reports.
2024-01-24 English
Stock Exchange Notification Lifecare Appointment of CFO
Board/Management Information Classification · 1% confidence The document is explicitly titled "STOCK EXCHANGE NOTIFICATION – LIFECARE – APPOINTMENT OF CFO". It announces the appointment of Renete Kaarvik as the Chief Financial Officer, detailing her background and the strategic reasons for the appointment. This directly corresponds to the definition of Board/Management Information (MANG), which covers announcements of changes in senior management.
2024-01-23 English
Stock Exchange Notification Lifecare Appointment of CFO
Board/Management Information Classification · 1% confidence The document is titled 'Stock Exchange Notification Lifecare Appointment of CFO' and explicitly announces the appointment of a new Chief Financial Officer (Renete Kaarvik) effective May 1, 2024. This directly relates to changes in senior management. According to the definitions, 'Board/Management Information (Code: MANG)' covers the 'Announcement of changes in the company's board of directors or senior management.' The document concludes with regulatory submission information ('Securities Trading Act § 5-12 and MAR Article 19 no. 3'), confirming it is an official regulatory disclosure regarding management changes.
2024-01-23 English
LIFE Successfully ISO 13485 certified
Environmental & Social Information Classification · 1% confidence The document is a press release dated January 9th, 2024, announcing that Lifecare Laboratory has received ISO 13485 certification. It discusses quality management systems, regulatory processes (like CE marking), and includes quotes from the CEO. This type of announcement, detailing operational milestones, quality certifications, or significant non-financial updates, does not fit neatly into the primary financial reporting categories (10-K, IR, ER, MRQ). It is a general regulatory/operational disclosure. Since it is a specific announcement that doesn't match AGM-R, 10-K, AR, MANG, CT, CAP, DVA, DLST, DIRS, ER, SR, FS, CGR, IRAT, IR, IP, LTR, TAR, NAV, DIV, PSI, DEF 14A, RPA, SHA, or POS, the most appropriate fallback category is Regulatory Filings (RNS), as it is a formal disclosure submitted under securities regulations (Securities Trading Act § 5-12 and MAR Article 19).
2024-01-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.